Bacteria battling a shield

The Silent Spread: How 'Superbugs' Like NDM-19 Threaten Our Future

Author's portrait.
Rhea Morgan in Health & Wellness August 2025 • 4 min read.

"Unpacking the rise of antibiotic-resistant bacteria and what it means for public health in an era of global interconnectedness."


In an era defined by unprecedented global interconnectedness, the specter of antibiotic resistance looms large, casting a shadow over modern medicine. What was once a triumph of science – the ability to swiftly and effectively combat bacterial infections – is now imperiled by the rise of 'superbugs': microorganisms that have evolved to resist the very drugs designed to eradicate them. These pathogens pose a significant threat to public health, potentially reversing decades of progress in treating infectious diseases.

Among the most concerning of these superbugs are carbapenem-resistant Enterobacteriaceae (CRE), particularly strains of Klebsiella pneumoniae. CRE infections are notoriously difficult to treat, often leaving clinicians with few or no effective options. Adding to this challenge is the emergence of New Delhi metallo-β-lactamase (NDM), an enzyme that confers resistance to a broad range of beta-lactam antibiotics, including carbapenems. NDM-producing bacteria have been identified worldwide, further complicating the fight against antibiotic resistance.

Recent research has shed light on a particularly alarming strain: NDM-19-producing Klebsiella pneumoniae. This strain, identified in China, carries two resistance plasmids, mobile genetic elements that facilitate the rapid spread of antibiotic resistance genes. Understanding the genetic characteristics of this strain is crucial to developing strategies to contain its spread and mitigate its potential impact on public health.

Decoding the NDM-19 Threat: Genetic Insights and Resistance Mechanisms

Bacteria battling a shield

A recent study delved into the genetic makeup of an NDM-19-producing Klebsiella pneumoniae strain, providing valuable insights into its resistance mechanisms and potential for dissemination. Researchers conducted whole-genome sequencing (WGS) of the strain, revealing a complex genetic architecture that facilitates antibiotic resistance. The study's findings underscore the urgency of addressing the growing threat of antibiotic resistance and highlight the importance of genomic surveillance in tracking the spread of these dangerous pathogens.

The Klebsiella pneumoniae strain examined in the study was found to harbor two plasmids, designated pSCM96-1 and pSCM96-2. These plasmids carry a variety of antibiotic resistance genes, contributing to the strain's multidrug-resistant phenotype. Of particular concern is the presence of the blaNDM-19 gene on pSCM96-2, which confers resistance to carbapenem antibiotics. In addition to blaNDM-19, the plasmids also carry genes encoding resistance to other classes of antibiotics, including aminoglycosides, beta-lactams, and fluoroquinolones.

The presence of multiple resistance genes on mobile genetic elements like plasmids raises serious concerns about the potential for horizontal gene transfer, the process by which bacteria share genetic material. This study reinforces the potential for antibiotic resistance genes to spread rapidly among bacterial populations, leading to the emergence of new multidrug-resistant strains. The key findings of the genetic makeup were:
The study's findings provide valuable insights into the genetic mechanisms underlying antibiotic resistance in Klebsiella pneumoniae. By identifying the specific resistance genes and mobile genetic elements present in this strain, researchers can develop targeted strategies to combat its spread. These strategies may include improved infection control measures, antimicrobial stewardship programs, and the development of new antibiotics that are effective against resistant strains.

Turning the Tide: Strategies for Combating Antibiotic Resistance

The rise of antibiotic-resistant bacteria like NDM-19-producing Klebsiella pneumoniae poses a formidable challenge to public health. However, by understanding the genetic mechanisms that drive resistance and implementing targeted strategies, we can turn the tide against these dangerous pathogens. These strategies include enhanced infection control measures in hospitals and healthcare settings; prudent use of antibiotics in human and animal medicine to slow the development of resistance; investment in research to develop new antibiotics and alternative therapies; and global collaboration to track the spread of resistance and implement effective interventions.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

What exactly are superbugs, such as NDM-19-producing Klebsiella pneumoniae, and why are they such a threat?

Superbugs, like NDM-19-producing Klebsiella pneumoniae, are microorganisms that have evolved resistance to antibiotics, the drugs designed to kill them. This resistance arises from genetic changes within the bacteria, often through the acquisition of resistance genes. The implications of superbugs are far-reaching, potentially rendering common infections untreatable and undermining modern medical procedures that rely on effective antibiotics.

2

What are the key genetic components that make NDM-19-producing Klebsiella pneumoniae resistant to antibiotics, and how do these components facilitate the spread of resistance?

The NDM-19-producing Klebsiella pneumoniae strain harbors two plasmids, pSCM96-1 and pSCM96-2. These plasmids carry various antibiotic resistance genes, including blaNDM-19, which confers resistance to carbapenem antibiotics. The presence of multiple resistance genes on these mobile genetic elements contributes to the strain's multidrug-resistant phenotype. The genetic makeup facilitates horizontal gene transfer, the process by which bacteria share genetic material, allowing resistance genes to spread rapidly.

3

Why are carbapenem-resistant Enterobacteriaceae (CRE), like Klebsiella pneumoniae, so difficult to treat, especially with the emergence of NDM enzymes like NDM-19?

Carbapenem-resistant Enterobacteriaceae (CRE), especially strains of Klebsiella pneumoniae, are difficult to treat because they have resistance to carbapenems, which are often used as a last-resort antibiotic. The emergence of New Delhi metallo-β-lactamase (NDM) enzymes, such as NDM-19, further complicates treatment as they confer resistance to a broad range of beta-lactam antibiotics, including carbapenems. This leaves clinicians with limited or no effective treatment options.

4

What strategies can be implemented to combat the spread of antibiotic-resistant bacteria, particularly NDM-19-producing Klebsiella pneumoniae?

Strategies include enhanced infection control measures in healthcare settings to prevent the spread of resistant bacteria. Antimicrobial stewardship programs are also essential to promote the prudent use of antibiotics in human and animal medicine, reducing the selective pressure that drives the development of resistance. Investment in research to develop new antibiotics and alternative therapies is needed, as is global collaboration to track the spread of resistance and implement effective interventions.

5

How does whole-genome sequencing (WGS) contribute to our understanding and fight against antibiotic-resistant bacteria like NDM-19-producing Klebsiella pneumoniae?

Whole-genome sequencing (WGS) helps scientists understand the genetic makeup of antibiotic-resistant bacteria like NDM-19-producing Klebsiella pneumoniae. By analyzing the bacterial genome, researchers can identify specific resistance genes, mobile genetic elements like plasmids, and mutations that contribute to antibiotic resistance. This information is crucial for tracking the spread of resistance, developing targeted interventions, and designing new antibiotics that can overcome resistance mechanisms. Missing from this is the application of AI, and novel drug designs and screening tools.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.